LUSC - Lung squamous cell carcinoma Back

External References: Wikipedia National Cancer Institute Google Scholar

iCoMut Beta for


Highly significantly mutated genes
TP53
149 patients (83%)
MLL2
36 patients (20%)
CDKN2A
28 patients (15%)
PIK3CA
27 patients (15%)
NFE2L2
27 patients (15%)
KEAP1
22 patients (12%)
Significantly mutated genes
ARID1A
13 patients (7%)
RB1
12 patients (6%)
FBXW7
10 patients (5%)
HLA-A
6 patients (3%)
HRAS
5 patients (2%)
Genes near significance
FAT1
21 patients (11%)
NF1
20 patients (11%)
PTEN
14 patients (7%)
NOTCH1
14 patients (7%)
ARHGAP35
10 patients (5%)
NSD1
10 patients (5%)
ASXL1
9 patients (5%)
EP300
8 patients (4%)
RASA1
8 patients (4%)
EGFR
6 patients (3%)
FUBP1
4 patients (2%)
FGFR3
4 patients (2%)
STK11
3 patients (1%)
SERPINB13
2 patients (1%)
Click on a gene to see details.

Notes


• Gene name color indicates: known cancer genes | highly compelling novel candidate cancer genes | other candidates

Data details


Mutation list for LUSC
Q-Q plots for LUSC